Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis.

Anti-neutrophil cytoplasmic antibody-associated vasculitis central nervous system vasculitis diffuse alveolar haemorrhage

Journal

SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686

Informations de publication

Date de publication:
2021
Historique:
received: 21 10 2020
accepted: 01 04 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: epublish

Résumé

Diffuse alveolar haemorrhage and central nervous system vasculitis are life-threatening complications of anti-neutrophil cytoplasmic antibody-associated vasculitis. The simultaneous occurrence of diffuse alveolar haemorrhage and central nervous system vasculitis is a rare presentation of antibody-associated vasculitis. Its diagnosis by histopathology is difficult because biopsy is difficult to perform, and urgent treatment is needed. We report a case of a Japanese man with diffuse alveolar haemorrhage and central nervous system vasculitis associated with antibody-associated vasculitis. New classification criteria may be needed for diffuse alveolar haemorrhage and central nervous system vasculitis associated with systemic vasculitis. When antibiotic-resistant atypical bilateral pneumonia is noted in the acute phase of a cerebral stroke, with elements suggestive of vasculitis, clinicians should be aware that diffuse alveolar haemorrhage and central nervous system vasculitis may occur simultaneously.

Identifiants

pubmed: 33996089
doi: 10.1177/2050313X211011814
pii: 10.1177_2050313X211011814
pmc: PMC8082973
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2050313X211011814

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):904.e7-9
pubmed: 21640612
Front Neurol. 2019 Jan 10;9:1166
pubmed: 30687221
Chest. 1996 Nov;110(5):1305-16
pubmed: 8915239
Ann Rheum Dis. 2007 Feb;66(2):222-7
pubmed: 16901958
Intern Med. 2007;46(12):815-22
pubmed: 17575372
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):47-52
pubmed: 32476936
Nat Rev Rheumatol. 2019 Feb;15(2):91-101
pubmed: 30542206
Radiology. 2018 Apr;287(1):11-28
pubmed: 29558307
J Korean Med Sci. 2009 Apr;24(2):269-74
pubmed: 19399269
Neurology. 2006 Jan 24;66(2):165-71
pubmed: 16434647
Expert Rev Neurother. 2016 Aug;16(8):861-3
pubmed: 26967679
No To Shinkei. 1998 Jan;50(1):56-60
pubmed: 9493200
Ann Rheum Dis. 2016 Sep;75(9):1583-94
pubmed: 27338776
Ther Adv Neurol Disord. 2010 Jan;3(1):29-42
pubmed: 21180634
Clin Exp Immunol. 2021 Feb;203(2):209-218
pubmed: 33020895

Auteurs

Takashi Nawata (T)

Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Kaori Murakawa (K)

Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Kosaku Shiragami (K)

Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Department of Internal Medicine, Sento Hill Hospital, Ube, Japan.

Masaki Shibuya (M)

Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Makoto Kubo (M)

Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Masafumi Yano (M)

Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Classifications MeSH